ACHILLION PHARMACEUTICALS IN - COM (ACHN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2020

Type / Class
Equity / COM
Symbol
ACHN
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q2 0 $0 -$71,000 0
2020 Q1 0 $0 -$750,299,579 0
2019 Q4 125,157,371 $754,720,714 +$88,722,760 $6.03 130
2019 Q3 111,793,566 $402,467,208 +$6,372,019 $3.60 119
2019 Q2 109,792,930 $294,219,331 +$6,485,109 $2.68 109
2019 Q1 110,033,638 $325,717,416 +$25,029,510 $2.96 109
2018 Q4 103,174,808 $164,034,076 -$33,605,361 $1.59 115
2018 Q3 107,116,668 $394,148,580 -$2,421,416 $3.68 134
2018 Q2 108,529,588 $307,146,439 -$14,905,284 $2.83 119
2018 Q1 111,931,685 $415,229,446 +$9,339,559 $3.71 123
2017 Q4 113,311,223 $326,351,131 +$12,893,347 $2.88 146
2017 Q3 106,807,743 $479,577,489 +$21,882,893 $4.49 123
2017 Q2 101,828,813 $467,383,836 +$37,204,666 $4.59 128
2017 Q1 98,214,709 $413,469,375 +$38,206,029 $4.21 128
2016 Q4 99,526,045 $411,041,635 -$90,189,420 $4.13 136
2016 Q3 107,681,582 $871,701,309 -$13,441,907 $8.10 155
2016 Q2 109,277,591 $852,398,662 -$22,775,753 $7.80 138
2016 Q1 112,163,911 $865,703,000 -$39,291,673 $7.72 149
2015 Q4 115,403,935 $1,244,889,623 -$30,832,609 $10.79 149
2015 Q3 120,101,740 $829,824,451 +$84,439,089 $6.91 136
2015 Q2 107,235,189 $949,690,625 +$9,546,931 $8.86 156
2015 Q1 104,717,228 $1,032,389,524 +$146,146,013 $9.86 169
2014 Q4 88,604,708 $1,085,509,494 +$114,271,068 $12.25 177
2014 Q3 77,293,683 $771,377,348 -$59,189,140 $9.98 159
2014 Q2 82,861,193 $627,171,612 +$36,139,511 $7.57 114
2014 Q1 78,755,591 $259,051,008 -$1,519,992 $3.29 93